Natural Tregs, CD4+CD25+ inhibitory hybridomas, and their cell contact dependent suppression

被引:16
作者
Field, Elizabeth H.
Kulhankova, Katarina
Nasr, Mohamed E.
机构
[1] Univ Iowa, Med Ctr, Dept Vet Affairs, Iowa City, IA 52242 USA
[2] Univ Iowa, Grad Program Immunol, Iowa City, IA 52242 USA
[3] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Med, Iowa City, IA 52242 USA
关键词
treg; regulatory cells; CD25; IL-2; live cell imaging;
D O I
10.1007/s12026-007-0064-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The natural CD4+CD25+ T regulatory (Treg) lymphocyte has emerged as a critical cell for controlling immune responses to self, foreign proteins, and pathogens. Identified initially by the constitutive expression of CD4 and CD25, natural Tregs suppress a variety of immune cells and responses, including CD4+CD25- proliferation and IL-2 production. and CD8 cell proliferation, IFN gamma production and CTL activity. Although natural Tregs require activation with specific antigen to attain their suppressive phenotype, once activated they execute inhibition in an antigen specific as well as non-specific (bystander) fashion. Treg suppression depends on IL-2, CD25, and cell:cell contact. The use of live cell imaging in vivo and in vitro to visualize the dynamic cell:cell interactions involving natural Tregs as well as the CD4+CD25+ Treg inhibitory hybridoma RD6 has refined the mechanistic models of contact dependent Treg suppression.
引用
收藏
页码:62 / 78
页数:17
相关论文
共 117 条
[41]   Regulatory T cells induced by 1α,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance [J].
Gregori, S ;
Casorati, M ;
Amuchastegui, S ;
Smiroldo, S ;
Davalli, AM ;
Adorini, L .
JOURNAL OF IMMUNOLOGY, 2001, 167 (04) :1945-1953
[42]   Human T regulatory cells can use the perforin pathway to cause autologous target cell death [J].
Grossman, WJ ;
Verbsky, JW ;
Barchet, W ;
Colonna, M ;
Atkinson, JP ;
Ley, TJ .
IMMUNITY, 2004, 21 (04) :589-601
[43]   SPECIFIC UNRESPONSIVENESS IN RATS WITH PROLONGED CARDIAC ALLOGRAFT SURVIVAL AFTER TREATMENT WITH CYCLOSPORINE .3. FURTHER CHARACTERIZATION OF THE CD4+ SUPPRESSOR-CELL AND ITS MECHANISMS OF ACTION [J].
HALL, BM ;
PEARCE, NW ;
GURLEY, KE ;
DORSCH, SE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (01) :141-157
[44]   IL-30 is required for regulatory T cells to mediate tolerance to alloantigens in vivo [J].
Hara, M ;
Kingsley, CI ;
Niimi, M ;
Read, S ;
Turvey, SE ;
Bushell, AR ;
Morris, PJ ;
Powrie, F ;
Wood, KJ .
JOURNAL OF IMMUNOLOGY, 2001, 166 (06) :3789-3796
[45]  
Herbelin A, 1998, J IMMUNOL, V161, P2620
[46]   ACTIVE SUPPRESSION OF IMMUNOGLOBULIN ALLOTYPE SYNTHESIS .3. IDENTIFICATION OF T CELLS AS RESPONSIBLE FOR SUPPRESSION BY CELLS FROM SPLEEN, THYMUS, LYMPH-NODE, AND BONE-MARROW [J].
HERZENBERG, LA ;
CHAN, EL ;
RAVITCH, MM ;
RIBLET, RJ ;
HERZENBE.LA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1973, 137 (06) :1311-1324
[47]   Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation [J].
Hoffmann, P ;
Ermann, J ;
Edinger, M ;
Fathman, CG ;
Strober, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :389-399
[48]   THE ROLE OF CD40 AND ITS LIGAND IN THE REGULATION OF THE IMMUNE-RESPONSE [J].
HOLLENBAUGH, D ;
OCHS, HD ;
NOELLE, RJ ;
LEDBETTER, JA ;
ARUFFO, A .
IMMUNOLOGICAL REVIEWS, 1994, 138 :23-37
[49]   Role of LAG-3 in regulatory T cells [J].
Huang, CT ;
Workman, CJ ;
Flies, D ;
Pan, XY ;
Marson, AL ;
Zhou, G ;
Hipkiss, EL ;
Ravi, S ;
Kowalski, J ;
Levitsky, HI ;
Powell, JD ;
Pardoll, DM ;
Drake, CG ;
Vignali, DAA .
IMMUNITY, 2004, 21 (04) :503-513
[50]  
Itoh M, 1999, J IMMUNOL, V162, P5317